Verrica Pharmaceuticals Inc. (VRCA): Revenue

Annual figures by period end, from SEC filings.

$35.58M

Year ended 2025-12-31

$30.32M

Trailing 12 months to 2026-06-30

+57.9%

3-year compound annual growth

2021-12-31 Revenue (USD) 2025-12-31

Period ended	Revenue	Change YoY	Source filing
2025-12-31	$35.58M	+370.2%	2026-03-11, From 2025-01-01
2024-12-31	$7.57M	+47.7%	2026-03-11, From 2024-01-01
2023-12-31	$5.12M	-43.3%	2025-03-11, From 2023-01-01
2022-12-31	$9.03M	-24.7%	2024-02-29, From 2022-01-01
2021-12-31	$12.00M	n/a	2023-03-06, From 2021-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
Verrica Pharmaceuticals Inc. (VRCA)	2025-12-31	$35.58M	+370.2%
Earth Science Tech, Inc. (ETST)	2026-03-31	$35.70M	+7.8%
Sunshine Biopharma Inc. (SBFM)	2025-12-31	$36.31M	+4.1%
Bioharvest Sciences Inc. (BHST)	2025-12-31	$34.51M	+37.0%
Lftd Partners Inc. (LIFD)	2025-12-31	$36.92M	-1.1%
BGM Group Ltd. (BGM)	2025-09-30	$37.92M	+51.1%
Zomedica Corp. (ZOMDF)	2025-12-31	$32.03M	+17.4%
Verastem, Inc. (VSTM)	2025-12-31	$30.91M	+209.1%
Foghorn Therapeutics Inc. (FHTX)	2025-12-31	$30.91M	+36.8%

Compare VRCA, ETST, SBFM, BHST side by side · Screen every company in Pharmaceutical Preparations ↗